Schwartz Jonathan David

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Schwartz Jonathan David's trades of Rocket Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
21.38
Quantity 712
Value US$15,219
Transaction date
Proposed sale
Price
17.66
Quantity 10,880
Value US$192,141
Transaction date
Proposed sale
Price
17.11
Quantity 4,643
Value US$79,432
Transaction date
Proposed sale
Price
16.98
Quantity 12,390
Value US$210,404
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-13 2026-02-13
PrS Proposed sale
91,155
278.62
US$3,397,905 		91,155 278.62 US$3,397,905
2025-11-20 2025-11-18
S Sale
87,718 -14.5%
79.72
US$3,566,300 		87,718 -14.5% 79.72 US$3,566,300
2025-11-18 2025-11-18
PrS Proposed sale
62,918
82.22
US$2,027,194 		62,918 82.22 US$2,027,194
2025-08-20 2025-08-19
S Sale
805 -0.4%
3.00
US$2,412 		805 -0.4% 3.00 US$2,412
2025-08-19 2025-08-19
PrS Proposed sale
805
3.00
US$2,412 		805 3.00 US$2,412
2025-08-20 2025-08-18
S Sale
1,680 -0.7%
3.07
US$5,149 		1,680 -0.7% 3.07 US$5,149
2025-08-18 2025-08-18
PrS Proposed sale
1,680
3.07
US$5,150 		1,680 3.07 US$5,150
2025-08-18 2025-08-14
S Sale
11,161 -4.7%
3.02
US$33,695 		11,161 -4.7% 3.02 US$33,695
2025-08-14 2025-08-14
PrS Proposed sale
11,161
3.02
US$33,692 		11,161 3.02 US$33,692
2025-05-22 2025-05-20
S Sale
801 -0.3%
6.45
US$5,163 		801 -0.3% 6.45 US$5,163
2025-05-20 2025-05-20
PrS Proposed sale
801
6.45
US$5,163 		801 6.45 US$5,163
2025-05-20 2025-05-16
S Sale
1,582 -0.7%
6.53
US$10,327 		1,582 -0.7% 6.53 US$10,327
2025-05-16 2025-05-16
PrS Proposed sale
1,582
6.53
US$10,327 		1,582 6.53 US$10,327
2025-02-27 2025-02-25
S Sale
6,532 -2.7%
10.58
US$69,109 		6,532 -2.7% 10.58 US$69,109
2025-02-25 2025-02-25
PrS Proposed sale
6,532
10.58
US$69,117 		6,532 10.58 US$69,117
2025-02-27 2024-11-21
S Sale
3,097 -1.9%
13.05
US$40,416 		3,097 -1.9% 13.05 US$40,416
2025-02-27 2024-08-16
S Sale
2,710 -1.6%
18.50
US$50,135 		2,710 -1.6% 18.50 US$50,135
2025-02-27 2024-05-17
S Sale
2,754 -1.6%
23.35
US$64,306 		2,754 -1.6% 23.35 US$64,306
2023-05-17 2023-05-17
PrS Proposed sale
712
21.38
US$15,219 		712 21.38 US$15,219
2023-04-13 2023-04-13
PrS Proposed sale
10,880
17.66
US$192,141 		10,880 17.66 US$192,141
2023-04-11 2023-04-11
PrS Proposed sale
4,643
17.11
US$79,432 		4,643 17.11 US$79,432
2023-04-06 2023-04-06
PrS Proposed sale
12,390
16.98
US$210,404 		12,390 16.98 US$210,404
2023-02-22 2023-02-17
S Sale
3,557 -3.6%
19.06
US$67,796 		3,557 -3.6% 19.06 US$67,796
2022-04-01 2022-03-30
PlS Planned sale
34,438 -16.1%
16.56
US$570,293 		34,438 -16.1% 16.56 US$570,293
2022-04-01 2022-03-30
PlS Planned sale
10,562 -4.7%
15.94
US$168,358 		10,562 -4.7% 15.94 US$168,358